Re: Termination of the Development Collaboration and License AgreementDevelopment Collaboration and License Agreement • March 7th, 2024 • DBV Technologies S.A. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2024 Company IndustryNESTEC and DBV entered into the Agreement to establish a collaboration whereby DBV would develop a diagnostic test for CMPA using DBV’s proprietary Viaskin™ Technology, and NESTEC would receive a license to commercialize such diagnostic product. Through no fault of either party, and after both parties having used Commercially Reasonable Efforts to pursue the development and commercialization of a diagnostic test for CMPA, the parties desire to cease all activities under the Agreement, including, without limitation, all Development activities, and the parties desire to terminate the Agreement in its entirety in accordance with the terms of this letter (this “Letter”), effective as of the last date of signature hereof, (the “Effective Date”).
COMMERCIAL LEASECommercial Lease • March 7th, 2024 • DBV Technologies S.A. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2024 Company IndustrySCI DANTON MALAKOFF, a French non-trading real estate company with share capital of 1,000 euros, registered in the Paris Trade and Companies Register under number 838 690 071, whose registered office is located at 30 avenue Kleber 75116 PARIS,
BETWEEN THE UNDERSIGNED:Employment Agreement • March 7th, 2024 • DBV Technologies S.A. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2024 Company IndustryDBV Technologies, a French public limited company (société anonyme) with share capital of 9,625,355.30 euros, registered in the Nanterre Trade Register under number 441 772 522, with its head office at 171-181, avenue Pierre Brossolette 92120 Montrouge, represented by Caroline Danière, in her capacity as Group Human Resources Director, duly authorized to act on behalf of DBV Technologies.
LEASE AGREEMENTLease Agreement • March 7th, 2024 • DBV Technologies S.A. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledMarch 7th, 2024 Company Industry JurisdictionThis LEASE AGREEMENT (this “Lease”) is dated MARCH 28, 2022, and is between SIG 106 LLC, a New Jersey limited liability company (“Landlord”), and DBV TECHNOLOGIES, INC., a Delaware corporation (“Tenant”).